Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes

Condition(s) studied

Investigational drug(s) / intervention(s)

Exercise Program: An 8-week supervised strengthening and stretching program performed three times weekly, with advice to perform at least 150 minutes per week of moderate-intensity walking.

Self-Myofascial Release: Self-myofascial release applied to the plantar fascia and gastrosoleus muscles using a foam roller three times per week for eight weeks before exercise sessions.

Study summary

This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group. Both groups will complete an eight-week supervised exercise program three times per week. The intervention group will additionally perform self-myofascial release using a foam roller before exercise sessions. Outcomes will include foot function, balance, functional mobility, gait performance, and plantar fascia thickness assessed by ultrasonography before and after the intervention.

Eligibility

Primary outcome measure(s)

• Foot Function Index (FFI) — Baseline and 8 weeks
  The Foot Function Index will be used to assess pain and disability related to foot function.

Trial sites (1)

More Izmir Katip Celebi University trials in Turkey

Other trials for the same condition